UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials

PloS one, 2014-06, Vol.9 (6), p.e98175

2014

Volltextzugriff (PDF)

Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants

Clinical Microbiology Reviews, 2003-10, Vol.16 (4), p.647-657

2003

Volltextzugriff (PDF)

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region

Human molecular genetics, 2011-10, Vol.20 (19), p.3893-3898

2011

Volltextzugriff (PDF)

Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional study

International journal of STD & AIDS, 2024-10, Vol.35 (11), p.910-915

2024

Volltextzugriff (PDF)

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection

Annals of hepatology, 2016-09, Vol.15 (5), p.696-704

2016

Volltextzugriff (PDF)

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro‐elimination in the Utrecht province

Liver international, 2019-03, Vol.39 (3), p.455-462

2019

Volltextzugriff (PDF)

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection

Vaccine, 2016-07, Vol.34 (35), p.4166-4171

2016

Volltextzugriff (PDF)

The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands

AIDS (London), 2017-01, Vol.31 (1), p.105-112

2017

Volltextzugriff (PDF)

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence

Clinical and vaccine immunology, 2017-02, Vol.24 (2)

2017

Volltextzugriff (PDF)

Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara® )

Vaccine, 2010-06, Vol.28 (26), p.4288-4293

2010

Volltextzugriff (PDF)

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

Therapeutic drug monitoring, 2013-08, Vol.35 (4), p.546-551

2013

Volltextzugriff (PDF)

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students

Open forum infectious diseases, 2014-12, Vol.1 (3), p.ofu101-ofu101

2014

Volltextzugriff (PDF)

No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test

Journal of nephrology, 2011-09, Vol.24 (5), p.625-630

2011

Volltextzugriff (PDF)

Cytokine Polymorphisms Play a Role in Susceptibility to Ultraviolet B-Induced Modulation of Immune Responses after Hepatitis B Vaccination

The Journal of immunology (1950), 2003-03, Vol.170 (6), p.3423-3428

2003

Volltextzugriff (PDF)

No beneficial effects of amantadine in treatment of chronic hepatitis C patients

Digestive and liver disease, 2010-07, Vol.42 (7), p.496-502

2010

Volltextzugriff (PDF)

Occupational blood exposure accidents in the Netherlands

European journal of public health, 2010-06, Vol.20 (3), p.281-287

2010

Volltextzugriff (PDF)

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment

European journal of gastroenterology & hepatology, 2010-11, Vol.22 (11), p.1308-1315

2010

Volltextzugriff (PDF)

T1982 Ribavirin- Rather Than PEG-Interferon-Related Factors are Predicting Non-Response to Antiviral Therapy in Naive Chronic Hepatitis C Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-842-S-842

2010

Volltextzugriff (PDF)

T1983 Endogenous Erythropoietin Response and Predictive Factors for Anemia During Treatment With PEG-Interferon Alfa-2B and Ribavirin in Chronic Hepatitis C Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-842-S-842

2010

Volltextzugriff (PDF)

T1984 Influence of Ribavirin on Hepatitis C (HCV) Viral Kinetics at Various Time Points During PEG-Interferon and Ribavirin Treatment in Naive Hepatitis C Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-842-S-842

2010

Volltextzugriff (PDF)

Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination

World journal of gastroenterology : WJG, 2004-01, Vol.10 (2), p.260

2004

Volltextzugriff (PDF)

Influence of Ultraviolet B Exposure on Immune Responses Following Hepatitis B Vaccination in Human Volunteers

Journal of investigative dermatology, 2001-11, Vol.117 (5), p.1144-1150

2001

Volltextzugriff (PDF)

IL-1β gene polymorphisms influence hepatitis B vaccination

Vaccine, 2002-08, Vol.20 (25), p.3193-3196

2002

Volltextzugriff (PDF)

Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy

European journal of gastroenterology & hepatology, 2010-07, Vol.22 (7), p.808-812

2010

Volltextzugriff (PDF)

Epidermal cis-Urocanic Acid Levels Correlate with Lower Specific Cellular Immune Responses After Hepatitis B Vaccination of Ultraviolet B–exposed Humans

Photochemistry and photobiology, 2003-03, Vol.77 (3), p.271-275

2003

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials

Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants

A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region

Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional study

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection

REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro‐elimination in the Utrecht province

Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection

The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence

Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara® )

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

Mumps Serum Antibody Levels Before and After an Outbreak to Assess Infection and Immunity in Vaccinated Students

No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test

Cytokine Polymorphisms Play a Role in Susceptibility to Ultraviolet B-Induced Modulation of Immune Responses after Hepatitis B Vaccination

No beneficial effects of amantadine in treatment of chronic hepatitis C patients

Occupational blood exposure accidents in the Netherlands

Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment

T1982 Ribavirin- Rather Than PEG-Interferon-Related Factors are Predicting Non-Response to Antiviral Therapy in Naive Chronic Hepatitis C Patients

T1983 Endogenous Erythropoietin Response and Predictive Factors for Anemia During Treatment With PEG-Interferon Alfa-2B and Ribavirin in Chronic Hepatitis C Patients

T1984 Influence of Ribavirin on Hepatitis C (HCV) Viral Kinetics at Various Time Points During PEG-Interferon and Ribavirin Treatment in Naive Hepatitis C Patients

Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination

Influence of Ultraviolet B Exposure on Immune Responses Following Hepatitis B Vaccination in Human Volunteers

IL-1β gene polymorphisms influence hepatitis B vaccination

Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy

Epidermal cis-Urocanic Acid Levels Correlate with Lower Specific Cellular Immune Responses After Hepatitis B Vaccination of Ultraviolet B–exposed Humans

Suchergebnisse filtern